These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30452777)

  • 1. Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety Database.
    Tanoshima R; Khan A; Biala AK; Trueman JN; Drögemöller BI; Wright GEB; Hasbullah JS; Groeneweg GSS; Ross CJD; Carleton BC;
    J Clin Pharmacol; 2019 Mar; 59(3):356-363. PubMed ID: 30452777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS).
    Castro-Pastrana LI; Ghannadan R; Rieder MJ; Dahlke E; Hayden M; Carleton B
    J Popul Ther Clin Pharmacol; 2011; 18():e106-20. PubMed ID: 21467602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
    Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
    Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.
    Carleton B; Poole R; Smith M; Leeder J; Ghannadan R; Ross C; Phillips M; Hayden M
    Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):713-21. PubMed ID: 19507171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric adverse drug reaction reporting: understanding and future directions.
    Carleton BC; Smith MA; Gelin MN; Heathcote SC
    Can J Clin Pharmacol; 2007; 14(1):e45-57. PubMed ID: 17297195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adverse drug event manager facilitates spontaneous reporting of adverse drug reactions.
    Vinther S; Klarskov P; Borgeskov H; Darsø P; Christophersen AK; Borck B; Christensen C; Hansen MV; Halladin NM; Christensen MB; Harboe KM; Lund M; Jimenez-Solem E
    Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Analysis of Spontaneous Adverse Drug Reactions Reports Relating to Paediatric Patients.
    Rosli R; Ming LC; Abd Aziz N; Manan MM
    PLoS One; 2016; 11(6):e0155385. PubMed ID: 27249414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database.
    Castillon G; Salvo F; Moride Y
    Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017.
    Bukic J; Rusic D; Mas P; Karabatic D; Bozic J; Seselja Perisin A; Leskur D; Krnic D; Tomic S; Modun D
    BMC Pharmacol Toxicol; 2019 Oct; 20(1):60. PubMed ID: 31627740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of serious adverse drug reactions in pediatric oncology.
    Ross CJ; Visscher H; Rassekh SR; Castro-Pastrana LI; Shereck E; Carleton B; Hayden MR
    J Popul Ther Clin Pharmacol; 2011; 18():e134-51. PubMed ID: 21467604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions to local anaesthetics: a review of the French pharmacovigilance database.
    Fuzier R; Lapeyre-Mestre M; Samii K; Montastruc JL;
    Drug Saf; 2009; 32(4):345-56. PubMed ID: 19388725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Tremlett HL; Oger J
    Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions experience in a teaching hospital in Jordan.
    Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
    Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
    Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A
    BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
    van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
    Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.